A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

Mandeep Singh,Mustafa M. Kadhim,Abduladheem Turki Jalil,Shamam Kareem Oudah,Zafar Aminov,Fahad Alsaikhan,Zanko Hassan Jawhar,Andrés Alexis Ramírez-Coronel,Bagher Farhood
DOI: https://doi.org/10.1186/s12935-023-02936-4
IF: 6.429
2023-05-11
Cancer Cell International
Abstract:Although doxorubicin chemotherapy is commonly applied for treating different malignant tumors, cardiotoxicity induced by this chemotherapeutic agent restricts its clinical use. The use of silymarin/silibinin may mitigate the doxorubicin-induced cardiac adverse effects. For this aim, the potential cardioprotective effects of silymarin/silibinin against the doxorubicin-induced cardiotoxicity were systematically reviewed.
oncology
What problem does this paper attempt to address?